CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Wisconsin, Madison
About this trial
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI).
Participants will take Epidiolex (purified CBD) for 90 days
Eligibility criteria
Qualifiers
>18 years of age
History of supra-sacral spinal cord injury of any mechanism
Urinary incontinence with ≥2 episodes of urinary incontinence per day (outside of spinal shock)
Willingness to participate in drug intervention trial
Disqualifiers
History of intravesical Botox
Actively taking >15 mg of Oxybutynin single dose or equivalent dose of alternative anticholinergic medication for bladder symptoms
Use of Cannabis (any form) outside of study as determined by urine drug screen after washout period of 1 month if prior Cannabis use reported
Thought or mood disorder aside from depression
Trial design
Treatments tested in this trial
- CBD
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov